$ACHC
Acadia Healthcare Company, Inc.

2018 Q2 Form 10-Q Financial Statement

#000156459018018113 Filed on July 31, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $765.7M $715.9M
YoY Change 6.96% -5.37%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $520.6M $478.0M
YoY Change 8.91% -6.33%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $39.90M $35.20M
YoY Change 13.35% -4.09%
% of Gross Profit
Operating Expenses $696.5M $649.7M
YoY Change 7.2% -4.84%
Operating Profit $165.0M $162.2M
YoY Change 1.72% -5.81%
Interest Expense -$45.80M -$43.50M
YoY Change 5.29% -10.68%
% of Operating Profit -27.76% -26.82%
Other Income/Expense, Net
YoY Change
Pretax Income $69.26M $66.22M
YoY Change 4.59% -10.34%
Income Tax $10.37M $16.58M
% Of Pretax Income 14.97% 25.04%
Net Earnings $58.84M $49.63M
YoY Change 18.55% -12.07%
Net Earnings / Revenue 7.68% 6.93%
Basic Earnings Per Share $0.67 $0.57
Diluted Earnings Per Share $0.67 $0.57
COMMON SHARES
Basic Shares Outstanding 87.30M 86.95M
Diluted Shares Outstanding 87.47M 87.08M

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $79.50M $79.40M
YoY Change 0.13% 158.63%
Cash & Equivalents $79.46M $79.43M
Short-Term Investments
Other Short-Term Assets $80.50M $91.97M
YoY Change -12.47% 20.19%
Inventory $4.733M $4.917M
Prepaid Expenses $28.38M $26.00M
Receivables $329.3M $288.1M
Other Receivables $29.79M $30.69M
Total Short-Term Assets $489.2M $459.5M
YoY Change 6.47% 17.11%
LONG-TERM ASSETS
Property, Plant & Equipment $3.103B $2.866B
YoY Change 8.28% -12.47%
Goodwill $2.739B $2.710B
YoY Change 1.07% -4.3%
Intangibles $91.57M $84.98M
YoY Change 7.75% -0.02%
Long-Term Investments
YoY Change
Other Assets $51.07M $59.64M
YoY Change -14.36% 41.97%
Total Long-Term Assets $6.014B $5.769B
YoY Change 4.25% -8.32%
TOTAL ASSETS
Total Short-Term Assets $489.2M $459.5M
Total Long-Term Assets $6.014B $5.769B
Total Assets $6.503B $6.228B
YoY Change 4.42% -6.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $130.2M $81.40M
YoY Change 59.99% -24.78%
Accrued Expenses $182.4M $37.55M
YoY Change 385.7% -7.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $33.26M $34.81M
YoY Change -4.43% -52.59%
Total Short-Term Liabilities $394.1M $347.0M
YoY Change 13.59% -17.35%
LONG-TERM LIABILITIES
Long-Term Debt $3.188B $3.240B
YoY Change -1.63% -9.44%
Other Long-Term Liabilities $160.8M $171.7M
YoY Change -6.33% 13.22%
Total Long-Term Liabilities $3.349B $3.412B
YoY Change -1.86% -8.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $394.1M $347.0M
Total Long-Term Liabilities $3.349B $3.412B
Total Liabilities $3.821B $3.834B
YoY Change -0.33% -9.49%
SHAREHOLDERS EQUITY
Retained Earnings $538.2M $313.3M
YoY Change 71.78% 5.81%
Common Stock $2.531B $2.509B
YoY Change 0.88% 1.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.653B $2.377B
YoY Change
Total Liabilities & Shareholders Equity $6.503B $6.228B
YoY Change 4.42% -6.83%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income $58.84M $49.63M
YoY Change 18.55% -12.07%
Depreciation, Depletion And Amortization $39.90M $35.20M
YoY Change 13.35% -4.09%
Cash From Operating Activities $144.9M $130.6M
YoY Change 10.95% 5.15%
INVESTING ACTIVITIES
Capital Expenditures -$95.80M -$87.40M
YoY Change 9.61% -13.72%
Acquisitions
YoY Change
Other Investing Activities $800.0K -$800.0K
YoY Change -200.0% -99.23%
Cash From Investing Activities -$95.00M -$88.20M
YoY Change 7.71% -56.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -25.90M -9.500M
YoY Change 172.63% -111.71%
NET CHANGE
Cash From Operating Activities 144.9M 130.6M
Cash From Investing Activities -95.00M -88.20M
Cash From Financing Activities -25.90M -9.500M
Net Change In Cash 24.00M 32.90M
YoY Change -27.05% 4600.0%
FREE CASH FLOW
Cash From Operating Activities $144.9M $130.6M
Capital Expenditures -$95.80M -$87.40M
Free Cash Flow $240.7M $218.0M
YoY Change 10.41% -3.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-43505000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
68814000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
7655000
CY2017Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
9052000
CY2018Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2887000
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2017Q4 us-gaap Goodwill
Goodwill
2751174000
CY2018Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
88274373
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
79463000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67290000
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
329256000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
296925000
CY2018Q2 us-gaap Other Assets Current
OtherAssetsCurrent
80503000
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
107335000
CY2018Q2 us-gaap Assets Current
AssetsCurrent
489222000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
471550000
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3103331000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3048130000
CY2018Q2 us-gaap Goodwill
Goodwill
2739303000
CY2018Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
91566000
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
87348000
CY2018Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
3664000
CY2017Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
3731000
CY2018Q2 us-gaap Derivative Instruments And Hedges Noncurrent
DerivativeInstrumentsAndHedgesNoncurrent
24989000
CY2017Q4 us-gaap Derivative Instruments And Hedges Noncurrent
DerivativeInstrumentsAndHedgesNoncurrent
12997000
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
51072000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49572000
CY2018Q2 us-gaap Assets
Assets
6503147000
CY2017Q4 us-gaap Assets
Assets
6424502000
CY2018Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
33264000
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
34830000
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
130228000
achc Health Care Organization Patient Service Provision For Bad Debts
HealthCareOrganizationPatientServiceProvisionForBadDebts
19894000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
102299000
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
102840000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
99047000
CY2018Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
127786000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
141213000
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
394118000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
377389000
CY2018Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3187788000
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3205058000
CY2018Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
78340000
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
80333000
CY2018Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
160809000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
166434000
CY2018Q2 us-gaap Liabilities
Liabilities
3821055000
CY2017Q4 us-gaap Liabilities
Liabilities
3829214000
CY2018Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
28791000
CY2017Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
22417000
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
873000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
871000
CY2018Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2530083000
achc Health Care Organization Revenues
HealthCareOrganizationRevenues
1414984000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1507979000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1395090000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2517545000
CY2018Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-415883000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-374118000
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
538228000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
428573000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
2653301000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
2572871000
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6503147000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6424502000
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87330276
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87060114
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87330276
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87060114
CY2018Q2 achc Health Care Organization Revenues
HealthCareOrganizationRevenues
765738000
CY2017Q2 achc Health Care Organization Revenues
HealthCareOrganizationRevenues
725643000
achc Health Care Organization Revenues
HealthCareOrganizationRevenues
1507979000
CY2017Q2 achc Health Care Organization Patient Service Provision For Bad Debts
HealthCareOrganizationPatientServiceProvisionForBadDebts
9747000
us-gaap Professional Fees
ProfessionalFees
107479000
us-gaap Professional Fees
ProfessionalFees
89730000
us-gaap Supplies Expense
SuppliesExpense
59497000
us-gaap Supplies Expense
SuppliesExpense
56348000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
66216000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
40524000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
38406000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
175513000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
166833000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
79701000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-91055000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-86262000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-810000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
13171000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
649680000
us-gaap Operating Expenses
OperatingExpenses
1390633000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
765738000
CY2017Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
715896000
CY2018Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
416741000
CY2017Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
383595000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
828269000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
760016000
CY2018Q2 us-gaap Professional Fees
ProfessionalFees
53461000
CY2017Q2 us-gaap Professional Fees
ProfessionalFees
46321000
CY2018Q2 us-gaap Supplies Expense
SuppliesExpense
30133000
CY2017Q2 us-gaap Supplies Expense
SuppliesExpense
28639000
CY2018Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
20236000
CY2017Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
19435000
CY2018Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
87282000
CY2017Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
83122000
CY2018Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
39928000
CY2017Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
35201000
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
114700000
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16578000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7582000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30289000
CY2017Q2 us-gaap Profit Loss
ProfitLoss
49638000
us-gaap Profit Loss
ProfitLoss
109764000
us-gaap Profit Loss
ProfitLoss
84411000
CY2017Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
109000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-177000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
49630000
us-gaap Net Income Loss
NetIncomeLoss
109655000
us-gaap Net Income Loss
NetIncomeLoss
84588000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.97
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86954000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87205000
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87080000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
119122000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
9054000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-14952000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
188581000
CY2017Q2 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
-6500000
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-114492000
CY2018Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-45812000
CY2017Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-810000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-940000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
696480000
us-gaap Operating Expenses
OperatingExpenses
1280390000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
69258000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
117346000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10368000
CY2018Q2 us-gaap Profit Loss
ProfitLoss
58890000
CY2018Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
54000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
58836000
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.26
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87303000
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87467000
CY2018Q2 us-gaap Share Based Compensation
ShareBasedCompensation
7129000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
109000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-177000
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
132622000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
67890000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
188758000
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
3200000
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
-12100000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4845000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
17096000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6558000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22404000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-20457000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1809000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4893000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-9157000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
5257000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-829000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
187606000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
117521000
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
22850000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
5938000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-146309000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
17275000
achc Common Stock Withheld For Minimum Statutory Taxes Net
CommonStockWithheldForMinimumStatutoryTaxesNet
3678000
CY2018Q2 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
10500000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
22371000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
79434000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
626000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5124000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3978000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1040000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
26104000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-9953000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2761000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
21066000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4364000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-793000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
217886000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
188435000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-572000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
217314000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
161555000
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
8857000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
3337000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-173749000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
23246000
achc Common Stock Withheld For Minimum Statutory Taxes Net
CommonStockWithheldForMinimumStatutoryTaxesNet
2134000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-5172000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2270000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-30552000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23223000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-840000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
4297000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12173000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57063000
us-gaap Charity Care Direct And Indirect Cost Basis Amount
CharityCareDirectAndIndirectCostBasisAmount
3000000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
146000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
138000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1100000
CY2018Q2 achc Number Of Beds
NumberOfBeds
17900
achc Number Of Facilities
NumberOfFacilities
585
CY2018Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
40
achc Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P7Y10M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M1D
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
259300
CY2018Q2 achc Debt Instrument Unamortized Issuance Costs Discount Premium Net
DebtInstrumentUnamortizedIssuanceCostsDiscountPremiumNet
46022000
CY2017Q4 achc Debt Instrument Unamortized Issuance Costs Discount Premium Net
DebtInstrumentUnamortizedIssuanceCostsDiscountPremiumNet
50432000
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
87367
CY2018Q2 achc Net Cost Report Settlement Due From Due To
NetCostReportSettlementDueFromDueTo
12200000
CY2017Q4 achc Net Cost Report Settlement Due From Due To
NetCostReportSettlementDueFromDueTo
9000000
CY2018Q1 us-gaap Charity Care Direct And Indirect Cost Basis Amount
CharityCareDirectAndIndirectCostBasisAmount
1200000
CY2017Q1 us-gaap Charity Care Direct And Indirect Cost Basis Amount
CharityCareDirectAndIndirectCostBasisAmount
1400000
us-gaap Charity Care Direct And Indirect Cost Basis Amount
CharityCareDirectAndIndirectCostBasisAmount
2800000
CY2018Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
164000
CY2017Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
126000
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1600000
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1600000
CY2018Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3247000
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3247000
CY2018Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
91566000
CY2017Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
87348000
CY2018Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
94813000
CY2017Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
90595000
CY2018Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3247000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3247000
CY2018Q2 achc Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Amortization
IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedAmortization
0
CY2017Q4 achc Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Amortization
IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedAmortization
0
CY2018Q2 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
3247000
CY2017Q4 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
3247000
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3525133000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3395549000
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
421802000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
347419000
CY2018Q2 us-gaap Long Term Debt
LongTermDebt
3221052000
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
3239888000
CY2017Q4 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
22500000
CY2018Q2 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
15000000
CY2014Q4 achc Consolidated Funded Debt Maximum
ConsolidatedFundedDebtMaximum
40000000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8200000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3221669
achc Share Based Compensation Arrangement By Share Based Payment Award
ShareBasedCompensationArrangementByShareBasedPaymentAward
0.25
achc Share Based Compensation Arrangement By Share Based Payment Stock Options Granted Term
ShareBasedCompensationArrangementByShareBasedPaymentStockOptionsGrantedTerm
P10Y
us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
56500000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y3M18D
CY2018Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1000946
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
198313
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
974566
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
353800
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
8689
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
86112
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1233565
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
405634
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
541589
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
49.42
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
42.25
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
25.92
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
54.71
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.264
CY2018Q2 achc Accrued Expense Current
AccruedExpenseCurrent
32113000
us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
1395090000
us-gaap Operating Income Loss
OperatingIncomeLoss
298589000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
47.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.022
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
37.36
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
25.87
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
51.97
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.70
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
41.20
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
44.53
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2017 achc Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y3M18D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M15D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y1M9D
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8166000
CY2017 achc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
205000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1636000
CY2017 achc Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodAggregateIntrinsicValue
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3802000
achc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
137000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
134000
achc Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodAggregateIntrinsicValue
0
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2764000
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3549000
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2494000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.61
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.39
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.020
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.38
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.33
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
CY2018Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.150
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.250
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.065
achc New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption On Income Tax Provision
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionOnIncomeTaxProvision
1600000
achc New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption On Income Tax Provision
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionOnIncomeTaxProvision
1700000
achc New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption On Income Tax Provision As Percentage
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionOnIncomeTaxProvisionAsPercentage
0.014
achc New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption On Income Tax Provision As Percentage
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionOnIncomeTaxProvisionAsPercentage
0.015
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
achc Transition Tax On Certain Repatriated Earnings Of Foreign Subsidiaries Payable Period
TransitionTaxOnCertainRepatriatedEarningsOfForeignSubsidiariesPayablePeriod
P8Y
achc Tax Cuts And Jobs Act Of2017 Incomplete Accounting Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit
19300000
CY2018Q2 achc Tax Cuts And Jobs Act Of2017 Incomplete Accounting One Time Transition Tax Liability For Foreign Subsidiaries
TaxCutsAndJobsActOf2017IncompleteAccountingOneTimeTransitionTaxLiabilityForForeignSubsidiaries
0
CY2018Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
19300000
achc Tax Cuts And Jobs Act Of2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense
TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense
0
achc Income Tax Reconciliation Foreign Dividends And Earnings Taxable
IncomeTaxReconciliationForeignDividendsAndEarningsTaxable
10900000
CY2018Q2 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
25000000
us-gaap Malpractice Insurance Annual Coverage Limit
MalpracticeInsuranceAnnualCoverageLimit
75000000
achc Number Of Facilities Operated By Non Wholly Owned Subsidiaries
NumberOfFacilitiesOperatedByNonWhollyOwnedSubsidiaries
4
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
6265000
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-109000
CY2018Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
28379000
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
27320000
CY2018Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
29791000
CY2017Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
30455000
CY2018Q2 achc Workers Compensation Deposits
WorkersCompensationDeposits
10000000
CY2017Q4 achc Workers Compensation Deposits
WorkersCompensationDeposits
10000000
CY2018Q2 us-gaap Inventory Net
InventoryNet
4733000
CY2017Q4 us-gaap Inventory Net
InventoryNet
4787000
CY2018Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3885000
CY2017Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
15056000
CY2018Q2 us-gaap Insurance Receivable For Malpractice Current
InsuranceReceivableForMalpracticeCurrent
1688000
CY2017Q4 us-gaap Insurance Receivable For Malpractice Current
InsuranceReceivableForMalpracticeCurrent
17588000
CY2018Q2 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
2027000
CY2017Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
2129000
CY2018Q2 us-gaap Interest Payable Current
InterestPayableCurrent
33156000
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
36370000
CY2018Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
32362000
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
31342000
CY2017Q4 achc Accrued Expense Current
AccruedExpenseCurrent
37268000
CY2018Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
8966000
CY2017Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1012000
CY2018Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
6888000
CY2017Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
22788000
CY2018Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
4530000
CY2017Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
3945000
CY2018Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9771000
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8488000
CY2018Q2 us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
765738000
CY2017Q2 us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
715896000
us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
1507979000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
165014000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
162220000
us-gaap Operating Income Loss
OperatingIncomeLoss
310745000
achc Goodwill Increase From Contribution Of Redeemable Noncontrolling Interests
GoodwillIncreaseFromContributionOfRedeemableNoncontrollingInterests
2244000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-14877000
us-gaap Indefinite Lived Intangible Assets Purchase Accounting Adjustments
IndefiniteLivedIntangibleAssetsPurchaseAccountingAdjustments
762000

Files In Submission

Name View Source Status
0001564590-18-018113-index-headers.html Edgar Link pending
0001564590-18-018113-index.html Edgar Link pending
0001564590-18-018113.txt Edgar Link pending
0001564590-18-018113-xbrl.zip Edgar Link pending
achc-10q_20180630.htm Edgar Link pending
achc-20180630.xml Edgar Link completed
achc-20180630.xsd Edgar Link pending
achc-20180630_cal.xml Edgar Link unprocessable
achc-20180630_def.xml Edgar Link unprocessable
achc-20180630_lab.xml Edgar Link unprocessable
achc-20180630_pre.xml Edgar Link unprocessable
achc-ex311_8.htm Edgar Link pending
achc-ex312_7.htm Edgar Link pending
achc-ex32_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending